genomics

By Dave Muoio June 13, 2019
Genome Medical — a company that offers patient-facing virtual visits and provider-facing consultations with genetic experts — has raised $23 million in Series B funding. The round brings Genome Medical to $46 million in total funding. The round was led by Echo Health Ventures, with participation from LRVHealth, Casdin Capital, Perceptive Advisors, Manatt Venture Fund and Dreamers Fund, as well as...
By Dave Muoio June 11, 2019
Mount Sinai’s Icahn School of Medicine has revealed plans for a new center for research, development and implementation of artificial intelligence for healthcare. Called the Hamilton and Amabel James Center for Artificial Intelligence and Human Health, the Manhattan site is scheduled to open its doors sometime in the later part of 2021. The school is looking to have roughly 40 principal...
By Laura Lovett June 11, 2019
Less than a year after the blockchain-enabled genome sequencing startup's launch, Nebula Genomics is announcing its first pharma partnership with Merck KGaA’s EMD Serono. This early partnership will come in the form of a pilot program.  As part of the deal, EMD Serono will be able to use Nebula’s network of anonymized genomic data. This new pilot is specifically zeroing in on lung cancer patients...
Doctor talking to patient
By Piers Ford February 13, 2019
Mendelian, a UK healthtech startup, has received a £500,000 grant from Innovate UK to build platforms that will help GPs to identify NHS patients with potentially rare or hard-to-diagnose conditions and diseases more quickly. The two-year £940,000 project is based on Mendelian’s specialised screening system, which provides augmented and automated data analysis to assist with the accurate...
By Laura Lovett December 11, 2018
A new company called LunaDNA has created an avenue for people to donate their health data in exchange for shares in the company. The novel platform seeks to serve the needs of nonprofit and for-profit researchers as well as everyday people willing to share their health data.  “What we aim to do is create a human health database, inclusive of DNA data, clinical, medical, contextual information....

Scientist working in the lab at Helix. Photo courtesy of Helix. 

By Laura Lovett June 15, 2018
In the last few years consumer genomics has grown in both its offerings and legitimacy. The industry that was once best known for telling clients if they were Italian or Hungarian is now securing its foothold within the healthcare space.    Whether it is uniting women switched at birth 72-years prior or settling neighborly feuds, consumer genomics have caught the public’s interest. The highest...
By Laura Lovett May 16, 2018
DNA, health records, and blood test results are not only intimately personal, they are also a valuable asset to researchers. Recently a smattering of companies have been working to create a market for people to share and sell their personal data to researchers and healthcare players. Those efforts are going one step further, as two growing names in the health data and blockchain industry are...
By Bernie Monegain March 1, 2018
Helix has closed a $200 million financing round and said it plans to expand its personal genomics marketplace to accelerate consumer adoption of genomics. The San Carlos, California-based startup launched the Helix marketplace in July 2017 to collects and sequence a DNA sample once, and then store and protects a customer’s data so they can access additional DNA-powered products and services from...
By Heather Mack March 15, 2017
Seattle-based venture capital firm Biomatics Capital, which focuses on companies innovating around healthcare and technology, has closed its initiatory fund of $200 million. This exceeds the firm’s target of $150 million and spans a range of investors including individuals, family offices and institutions. Biomatics is particularly interested in genomics and digital health, and will use this fund...